PAHC

Phibro Animal Health Corporation Class A Common Stock

HealthcareDrug Manufacturers - Specialty & GenericUnited StatesNASDAQ

$56.89

+4.04%today

MKT CAP

$2.3B

-4.6% · 1Y

Full Financials

Trailing P/E19.1x

Forward P/E12.7x

EV/EBITDA-

Price/Sales-

Dividend Yield82.00%

Revenue Growth YoY-

Earnings Growth YoY-

Revenue Growth QoQ+2.7%

5y Revenue CAGR+11.2%

5y Earnings CAGR-0.6%

Gross Margin-

Operating Margin-

Net Margin-

ROE-

Debt / Equity-

Free Cash Flow-

Insider Ownership1.0%

Institutional Ownership97.6%

Short % of Float7.22%

Days to Cover3.8d

1 Week+4.6%

1 Month-

3 Months-

6 Months-

YTD-

1 Year-

3 Years-

5 Years-

vs 50-day SMA-

vs 200-day SMA-

vs 52w High-

vs 52w Low-

Peers

Ticker	Cap	Score	P/E	Fwd P/E	EV/EBITDA	ROE	Gross	D/E	Div
HCM HUTCHMED (China) Limited American Depositary Shares	$2.3B	67	5.0	25.5	-	-	-	-	0.00%
BCRX BioCryst Pharmaceuticals Inc. Common Stock	$2.3B	80	-	11.7	-	-	-	-	0.00%
PBH Prestige Consumer Healthcare Inc. Common Stock	$2.5B	80	14.3	11.3	-	-	-	-	0.00%
BHC Bausch Health Companies Inc. Common Stock	$2.1B	100	-	1.4	-	-	-	-	0.00%
ANIP ANI Pharmaceuticals Inc.	$1.9B	73	25.3	7.9	-	-	-	-	0.00%
SUPN Supernus Pharmaceuticals Inc. Common Stock	$3.0B	80	-	11.5	-	-	-	-	0.00%